Bundamedik Tbk vs Citra Marga Nusaphala Persada Tbk. — how do they compare? Bundamedik Tbk trades at Rp176 (market cap 1.51T, 536.7K 24h volume), while Citra Marga Nusaphala Persada Tbk. trades at Rp1,345 (market cap 9.11T, 96.2K 24h volume). The key difference: Citra Marga Nusaphala Persada Tbk. is far larger — about 6× Bundamedik Tbk's market cap, and Bundamedik Tbk is more actively traded (536.7K versus 96.2K). Which is the better fit depends on your goals.
| BMHS | CMNP | |
|---|---|---|
Market Cap | 1.51T | 9.11T |
Volume | 536.7K | 96.2K |
Lot | 5.37K | 962 |
Turnover | 93.41M | 129.18M |
Average Price | 174.05 | 1,342.87 |
Value | 93.41M | 129.18M |
Indicative Equilibrium Price | 176 | 1,345 |
Indicative Equilibrium Volume | 100 | 2 |
Trailing returns across standard periods
Latest headlines on both assets
PT Bundamedik Tbk (the “Company”) was established on 13 April 1978 based on Notarial Deed No. 21 of Adlan Yulizar, S.H. The Company strated its commercial operations in 1978. The Company’s parent and ultimate parent of the group is PT Bunda Investama Indonesia.
Read more on BMHS →PT Citra Marga Nusaphala Persada Tbk (the Company) was established within the framework of the Domestic Investment Law No. 6 of 1968, as amended by Law No. 12 of 1970 based on Notarial Deed No. 58 dated April 13, 1987 of Kartini Muljadi, S.H.The Company derives its revenues primarily from tollgate proceeds, project management fees and, to a lesser extent, from services related to the operations of a toll way system. The Company started commercial operations on March 1990. On June 19th, 1996, the Tanjung Priok – Jembatan Tiga toll road started commercial operations.
Read more on CMNP →